Efficacy of Preoperative Chemotherapy in Treatment of Children With Wilms’ Tumor: A Meta-Analysis

Highlights

References

• 1.
  SIOP PODC: clinical guidelines for the management of children with Wilms tumour in a low income setting.
• 2.
  Epidemiology of Wilms tumor.
• 3.
  Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial.
• 4.
  Preoperative regimen and surgery time in children Wilms' tumor.
• 5.
  Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
• 6.
  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
• 7.
  Meta-analysis in clinical trials.
• 8.
  Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
• 9.
  Operating characteristics of a rank correlation test for publication bias.
• 10.
  Evaluation of preoperative chemotherapy project and selection of operative time of nephroblastoma in children.
• 11.
  The analysis of preoperative chemotherapy in late stage patients with wilms' tumor.
• 12.
  Clinical analysis of preoperative chemotherapy in patients with wilms' tumor.
• 13.
  The influence of preoperative chemotherapy in children with wilms' tumor.
• 14.
  The pathology changes after preoperative chemotherapy in patients with wilms' tumor.
• 15.
  Preoperative chemotherapy in late stage patients with wilms' tumor.
• 16.
  Intratumoral chemotherapy in wilms' tumor.
• 17.
  The 57 cases of wilms' tumor.
• 18.
  A retrospective study of the preoperative treatment of advanced Wilms tumor in children with chemotherapy versus transcatheter arterial chemoembolization alone or combined with short-term systemic chemotherapy.
• 19.
  The efficacy of preoperative chemotherapy in wilms' tumor.
• 20.
  The advantages of preoperative chemotherapy in patients with wilms' tumor.
• 21.
  Treatment of advanced wilms' tumor.
• 22.
  Multidisciplinary approach to wilms' tumor: a retrospective analytical study of 53 patients.
• 23.
  Multidisciplinary approach to Wilms' tumor: 18 years of experience.
• 24.
  Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
• 25.
  From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
• 26.
  Does preoperative chemotherapy ease the surgical procedure for Wilms tumor?
• 27.
  Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy.
• 28.
  Intracaval and intracardiac extension of Wilms' tumor. The influence of preoperative chemotherapy on surgical morbidity.
• 29.
  Childhood renal tumours with intravascular extension.
• 30.
  Conservative surgical management of bilateral Wilms tumor: results of the United Kingdom Children's Cancer Study Group.
• 31.
  Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy.
• 32.
  Treatment of bilateral Wilms' tumor: comparison of initial biopsy and chemotherapy to initial surgical resection in the preservation of renal mass and function.
• 33.
  Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.
• 34.
  Preoperative care of infants with nephroblastoma. The International Society of Pediatric Oncology 6 experience.
• 35.
  Chemotherapy-induced histologic changes in Wilms' tumors.
• 36.
  Wilms' tumour: a comparison of surgical aspects in patients with or without pre-operative chemotherapy.
• 37.
  Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.O.P.).
• 38.
  Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
• 39.
  The treatment of Wilms' tumor: Results of the national Wilms' tumor study.
• 40.
  Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center.
• 41.
  Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
• 42.
  Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.
• 43.
  The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour.
• 44.
  The expression of p-glycoprotein in Wilms' tumor.